首页> 美国卫生研究院文献>Cell Division >Subunits of human condensins are potential therapeutic targets for cancers
【2h】

Subunits of human condensins are potential therapeutic targets for cancers

机译:人类凝缩蛋白的亚基是癌症的潜在治疗靶标

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The main role of condensins is to regulate chromosome condensation and segregation during cell cycles. Recently, it has been suggested in the literatures that subunits of condensin I and condensin II are involved in some human cancers. This paper will first briefly discuss discoveries of human condensins, their components and structures, and their multiple cellular functions. This will be followed by reviews of most recent studies on subunits of human condensins and their dysregulations or mutations in human cancers. It can be concluded that many of these subunits have potentials to be novel targets for cancer therapies. However, hCAP-D2, a subunit of human condensin I, has not been directly documented to be associated with any human cancers to date. This review hypothesizes that hCAP-D2 can also be a potential therapeutic target for human cancers, and therefore that all subunits of human condensins are potential therapeutic targets for human cancers.Electronic supplementary materialThe online version of this article (10.1186/s13008-018-0035-3) contains supplementary material, which is available to authorized users.
机译:凝集素的主要作用是调节细胞周期中的染色体凝缩和分离。最近,在文献中已经提出,凝缩蛋白I和凝缩蛋白II的亚基与某些人类癌症有关。本文将首先简要讨论人类凝缩素的发现,它们的成分和结构以及它们的多种细胞功能。接下来将回顾有关人类凝缩蛋白亚基及其在人类癌症中的失调或突变的最新研究。可以得出结论,这些亚基中的许多有可能成为癌症治疗的新靶标。然而,迄今为止,尚没有直接文献报道hCAP-D2是人类凝缩素I的亚基,与任何人类癌症都有关。这篇评论假设hCAP-D2也可能是人类癌症的潜在治疗靶标,因此人类凝缩蛋白的所有亚基都是人类癌症的潜在治疗靶标。电子补充材料本文的在线版本(10.1186 / s13008-018-0035 -3)包含补充材料,授权用户可以使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号